NO116870B - - Google Patents
Download PDFInfo
- Publication number
- NO116870B NO116870B NO16157266A NO16157266A NO116870B NO 116870 B NO116870 B NO 116870B NO 16157266 A NO16157266 A NO 16157266A NO 16157266 A NO16157266 A NO 16157266A NO 116870 B NO116870 B NO 116870B
- Authority
- NO
- Norway
- Prior art keywords
- cell
- cells
- antigen
- cell wall
- pertussis
- Prior art date
Links
- 210000004027 cell Anatomy 0.000 claims description 38
- 239000000463 material Substances 0.000 claims description 32
- 210000002421 cell wall Anatomy 0.000 claims description 24
- 239000000427 antigen Substances 0.000 claims description 18
- 102000036639 antigens Human genes 0.000 claims description 18
- 108091007433 antigens Proteins 0.000 claims description 18
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 17
- 238000000034 method Methods 0.000 claims description 16
- 201000005702 Pertussis Diseases 0.000 claims description 13
- 239000007788 liquid Substances 0.000 claims description 11
- 101710194807 Protective antigen Proteins 0.000 claims description 8
- 125000004432 carbon atom Chemical group C* 0.000 claims description 8
- 238000004519 manufacturing process Methods 0.000 claims description 8
- 239000000725 suspension Substances 0.000 claims description 8
- 241000588832 Bordetella pertussis Species 0.000 claims description 7
- 239000000203 mixture Substances 0.000 claims description 7
- 150000001299 aldehydes Chemical class 0.000 claims description 6
- 150000002576 ketones Chemical class 0.000 claims description 6
- 210000000805 cytoplasm Anatomy 0.000 claims description 5
- 238000000605 extraction Methods 0.000 claims description 5
- 150000001298 alcohols Chemical class 0.000 claims description 2
- 229960005486 vaccine Drugs 0.000 description 15
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 10
- 239000012153 distilled water Substances 0.000 description 10
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 7
- 238000005119 centrifugation Methods 0.000 description 7
- 239000013049 sediment Substances 0.000 description 7
- 241001465754 Metazoa Species 0.000 description 5
- 241000699670 Mus sp. Species 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 239000002609 medium Substances 0.000 description 4
- 229940031348 multivalent vaccine Drugs 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 239000006228 supernatant Substances 0.000 description 4
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 3
- 230000009172 bursting Effects 0.000 description 3
- 239000012141 concentrate Substances 0.000 description 3
- 238000010790 dilution Methods 0.000 description 3
- 239000012895 dilution Substances 0.000 description 3
- 229910001873 dinitrogen Inorganic materials 0.000 description 3
- 239000003755 preservative agent Substances 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 230000001681 protective effect Effects 0.000 description 3
- RTKIYNMVFMVABJ-UHFFFAOYSA-L thimerosal Chemical compound [Na+].CC[Hg]SC1=CC=CC=C1C([O-])=O RTKIYNMVFMVABJ-UHFFFAOYSA-L 0.000 description 3
- 229940033663 thimerosal Drugs 0.000 description 3
- 231100000331 toxic Toxicity 0.000 description 3
- 230000002588 toxic effect Effects 0.000 description 3
- 230000004580 weight loss Effects 0.000 description 3
- IKHGUXGNUITLKF-UHFFFAOYSA-N Acetaldehyde Chemical compound CC=O IKHGUXGNUITLKF-UHFFFAOYSA-N 0.000 description 2
- 241000588807 Bordetella Species 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- 239000002671 adjuvant Substances 0.000 description 2
- 229940037003 alum Drugs 0.000 description 2
- 238000010171 animal model Methods 0.000 description 2
- 238000005422 blasting Methods 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 239000007975 buffered saline Substances 0.000 description 2
- 239000000470 constituent Substances 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- 239000007928 intraperitoneal injection Substances 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 231100000252 nontoxic Toxicity 0.000 description 2
- 230000003000 nontoxic effect Effects 0.000 description 2
- 230000002335 preservative effect Effects 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 229920001817 Agar Polymers 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 241000700198 Cavia Species 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010022998 Irritability Diseases 0.000 description 1
- 206010028851 Necrosis Diseases 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 241000270295 Serpentes Species 0.000 description 1
- 229910000831 Steel Inorganic materials 0.000 description 1
- 244000223014 Syzygium aromaticum Species 0.000 description 1
- 235000016639 Syzygium aromaticum Nutrition 0.000 description 1
- 239000011149 active material Substances 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 1
- ILRRQNADMUWWFW-UHFFFAOYSA-K aluminium phosphate Chemical compound O1[Al]2OP1(=O)O2 ILRRQNADMUWWFW-UHFFFAOYSA-K 0.000 description 1
- 235000011126 aluminium potassium sulphate Nutrition 0.000 description 1
- 229940009859 aluminum phosphate Drugs 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 229960001950 benzethonium chloride Drugs 0.000 description 1
- UREZNYTWGJKWBI-UHFFFAOYSA-M benzethonium chloride Chemical compound [Cl-].C1=CC(C(C)(C)CC(C)(C)C)=CC=C1OCCOCC[N+](C)(C)CC1=CC=CC=C1 UREZNYTWGJKWBI-UHFFFAOYSA-M 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 229940030156 cell vaccine Drugs 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 229940028617 conventional vaccine Drugs 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 231100000517 death Toxicity 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 206010014599 encephalitis Diseases 0.000 description 1
- 239000002360 explosive Substances 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 238000000265 homogenisation Methods 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 238000002649 immunization Methods 0.000 description 1
- 230000003053 immunization Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000036512 infertility Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 230000010355 oscillation Effects 0.000 description 1
- 238000010422 painting Methods 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 229940050271 potassium alum Drugs 0.000 description 1
- GRLPQNLYRHEGIJ-UHFFFAOYSA-J potassium aluminium sulfate Chemical compound [Al+3].[K+].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O GRLPQNLYRHEGIJ-UHFFFAOYSA-J 0.000 description 1
- 238000005096 rolling process Methods 0.000 description 1
- 238000011076 safety test Methods 0.000 description 1
- 239000010959 steel Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 230000004584 weight gain Effects 0.000 description 1
- 235000019786 weight gain Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/099—Bordetella
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US43075665A | 1965-02-05 | 1965-02-05 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO116870B true NO116870B (OSRAM) | 1969-06-02 |
Family
ID=23708891
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO16157266A NO116870B (OSRAM) | 1965-02-05 | 1966-02-04 |
Country Status (9)
| Country | Link |
|---|---|
| BE (1) | BE676109A (OSRAM) |
| BR (1) | BR6676831D0 (OSRAM) |
| DK (1) | DK116019B (OSRAM) |
| ES (1) | ES323024A1 (OSRAM) |
| FR (2) | FR1592058A (OSRAM) |
| GB (1) | GB1109742A (OSRAM) |
| IL (1) | IL25042A (OSRAM) |
| NL (1) | NL6600706A (OSRAM) |
| NO (1) | NO116870B (OSRAM) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5750925A (en) * | 1980-09-12 | 1982-03-25 | Takeda Chem Ind Ltd | Preparation of pertussis toxoid |
| US4338299A (en) * | 1980-11-17 | 1982-07-06 | Dso "Pharmachim" | Vaccine against pertussis |
| HU188847B (en) * | 1983-02-22 | 1986-05-28 | Human Oltoanyagtermeloe Es Kutato Intezet,Hu | Process for producing liophylized combined vaccines |
-
1966
- 1966-01-19 NL NL6600706A patent/NL6600706A/xx unknown
- 1966-01-25 GB GB332166A patent/GB1109742A/en not_active Expired
- 1966-01-25 IL IL2504266A patent/IL25042A/xx unknown
- 1966-01-31 BR BR17683166A patent/BR6676831D0/pt unknown
- 1966-02-04 BE BE676109D patent/BE676109A/xx unknown
- 1966-02-04 FR FR1592058D patent/FR1592058A/fr not_active Expired
- 1966-02-04 DK DK57366A patent/DK116019B/da unknown
- 1966-02-04 NO NO16157266A patent/NO116870B/no unknown
- 1966-02-04 ES ES0323024A patent/ES323024A1/es not_active Expired
- 1966-05-03 FR FR60111A patent/FR5347M/fr not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| BR6676831D0 (pt) | 1973-09-11 |
| DK116019B (da) | 1969-12-01 |
| GB1109742A (en) | 1968-04-10 |
| NL6600706A (OSRAM) | 1966-08-08 |
| IL25042A (en) | 1969-05-28 |
| FR5347M (OSRAM) | 1967-09-04 |
| ES323024A1 (es) | 1967-01-01 |
| FR1592058A (OSRAM) | 1970-05-11 |
| BE676109A (OSRAM) | 1966-08-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US3172546A (en) | Size reduction of biological substances | |
| RU2520082C2 (ru) | Способ получения "теней"бактериальных клеток (bg) | |
| US3395219A (en) | Process for production of pertussis antigen | |
| NO310472B1 (no) | Biomasse og fremgangsmåte for fremstilling av virus/virusantigen | |
| NO116870B (OSRAM) | ||
| Foster et al. | Immunological role of Brucella abortus cell walls | |
| CN101144062B (zh) | 一种干酪乳杆菌菌株及其制品在禽类免疫中的应用 | |
| EP0666904A1 (en) | Attenuated strains of aeromonas salmonicida useful as fish vaccines | |
| NO116869B (OSRAM) | ||
| US5094954A (en) | Production of endospores from pasteuria by culturing with explanted tissue from nematodes | |
| Hale et al. | Occurrence of Erwinia amylovora on apple fruit in New Zealand | |
| CN101283821A (zh) | 一种制取木枣精华浓缩营养液的方法 | |
| NO117986B (OSRAM) | ||
| Elad et al. | Immunogenicity in calves of a crude ribosomal fraction of Trichophyton verrucosum: a field trial | |
| JP2001017158A (ja) | 桑黄菌糸体培養用培地組成物及びこれを用いる桑黄菌糸体の培養方法 | |
| Meneley et al. | Establishment of an Inactive Population | |
| Van Hall | Seasonal susceptibility of Mutsu apples to Pseudomonas syringae pv. papulans | |
| CN104396572A (zh) | 冬虫夏草菌种孢子分离提纯复壮方法 | |
| JPS5929221B2 (ja) | マイタケエキスを主成分とする健康飲料の製造法 | |
| CN1104861A (zh) | 花粉破壁与营养成分提取技术 | |
| SUMMANWAR et al. | Virus associated with coconut root (wilt) disease | |
| US2979856A (en) | Attractants for fruit flies | |
| CN106434570B (zh) | 一种狂犬病病毒裂解液及其应用 | |
| Olive et al. | A new species of the protostelid genus Schizoplasmodiopsis | |
| Bateson | Isolation of the crystalline parasporal bodies of Bacillus thuringiensis |